StoneX Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
StoneX Group's ARKG Position: Q1 2026 in Review
StoneX Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 8,746 shares — an estimated $253K sold.
StoneX Group first reported a position in ARKG in Q2 2020 and held it in 20 quarters. The position peaked at $1.06M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- StoneX Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- StoneX Group sold 8,746 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $253K.
- StoneX Group first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 20 quarters.
- StoneX Group's ARK Genomic Revolution ETF position peaked at $1.06M in Q4 2020.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.